Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: Dennis who wrote (327)	5/15/1998 4:56:00 PM
From: fred woodall	Read Replies (1) \| Respond to of 471

Not so bad/Not so good (WIRE) Little Revenue for the 4Q. Cyberonics Inc. Thursday said its sales and marketing teams reached their capacity in the third quarter of fiscal 1998, and it expects little revenue growth in the fourth quarter as a result. Cyberonics (CYBX), which makes nerve stimulation devices for the treatment of epilepsy and other neurological disorders, said it plans to expand its U.S. sales and marketing departments and expand education programs for patients and healthcare providers. Cyberonics said the increased investment will result in "significantly higher" fiscal 1999 operating expenses compared with fiscal 1998 operating expenses. The company hopes the expansion will increase the awareness and demand for its systems for the treatment of medically refractory epilepsy. Through the nine months ended March 31, 127 implanting centers ordered 839 systems. Wonder if outside help for the expansion is in progress? Might be talking big bucks here. Dennis if you wish I can send you a CYBX TA chart with indicators.